NewsBite

Analysis

Why US drug giants are so angry about Australia’s PBS

US pharmaceutical giants hope the protectionist Trump administration will force Australia to increase the price it pays for their drugs.

Michael Smith
Michael SmithHealth editor
EmailLinkedInTwitterFacebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Andrew Robb has first-hand experience of the influence pharmaceutical giants have over US presidents.

The former trade minister spent three sleepless days in Atlanta in 2015 resisting a US push for stronger intellectual property protection for American drugmakers during Trans-Pacific Trade Deal negotiations. The impasse threatened to derail the 12-nation agreement and the US president at the time, Barack Obama, intervened.

Loading...
Michael Smith is the health editor for The Australian Financial Review. He is based in Sydney. Connect with Michael on Twitter. Email Michael at michael.smith@afr.com
EmailLinkedInTwitterFacebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

License article

Read More

Latest In Healthcare & fitness

Fetching latest articles

Most Viewed In Companies

    The Australian Financial Review Magazine

    From left: Michael Schumacher, Roger Federer, Ash Barty, Mark Webber and Daniel Ricciardo have all been in “commercial marriages” with watch brands.

    BOSS Financial Review

    Kim Feitelberg established her haircare company, HairShots, in early 2023.

    Life & Leisure

    Rich List

    Nick Andrianakos, pictured in Greece’s Nafplio, where he had been building a hotel.

    Original URL: https://www.afr.com/companies/healthcare-and-fitness/why-us-drug-giants-are-so-angry-about-australia-s-pbs-20250320-p5ll10